Thymic regulatory T cell development: Role of signalling pathways and transcription factors

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Engel, Mark ^a   Sidwell, Tom ^b   Vasanthakumar, Ajithkumar ^b   Grigoriadis, George ^a   Banerjee, Ashish ^a  

^a MONASH UNIVERSITY   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; DNA METHYLTRANSFERASE 1; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; TRANSCRIPTION FACTOR;

CD4+ T LYMPHOCYTE; CELL MATURATION; CELL POPULATION; DNA METHYLATION; GENE REARRANGEMENT; HUMAN; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; METABOLISM; THYMUS;

ANTIGENS, CD28; DNA METHYLATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84885652433     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/617595     Document Type: Review

References (80)

1. Klein L., Hinterberger M., Wirnsberger G., Kyewski B., Antigen presentation in the thymus for positive selection and central tolerance induction. Nature Reviews Immunology 2009 9 12 833 844 2-s2.0-72949104779 10.1038/nri2669
2. Anderson M. S., Su M. A., Aire and T cell development. Current Opinion in Immunology 2011 23 2 198 206 2-s2.0-79953097064 10.1016/j.coi.2010.11.007
3. Griesemer A. D., Sorenson E. C., Hardy M. A., The role of the thymus in tolerance. Transplantation 2010 90 5 465 474 2-s2.0-77957272003 10.1097/TP.0b013e3181e7e54f
4. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M., Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α -chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. Journal of Immunology 1995 155 3 1151 1164 2-s2.0-0029150110
5. Sakaguchi S., Yamaguchi T., Nomura T., Ono M., Regulatory T cells and immune tolerance. Cell 2008 133 5 775 787 2-s2.0-43949105866 10.1016/j.cell.2008.05.009 (Pubitemid 351707693)
6. Sakaguchi S., Fukuma K., Kuribayashi K., Masuda T., Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participiation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. Journal of Experimental Medicine 1985 161 1 72 87 2-s2.0-0021997185 (Pubitemid 15169721)
7. Hori S., Nomura T., Sakaguchi S., Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 299 5609 1057 1061 2-s2.0-0347785480 10.1126/science.1079490 (Pubitemid 36222930)
8. Fontenot J. D., Gavin M. A., Rudensky A. Y., Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunology 2003 4 4 330 336 2-s2.0-0037385330 10.1038/ni904 (Pubitemid 36432314)
9. Khattri R., Cox T., Yasayko S. A., Ramsdell F., An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nature Immunology 2003 4 4 337 342 2-s2.0-0037385314 10.1038/ni909 (Pubitemid 36432315)
10. Fontenot J. D., Dooley J. L., Farr A. G., Rudensky A. Y., Developmental regulation of Foxp3 expression during ontogeny. Journal of Experimental Medicine 2005 202 7 901 906 2-s2.0-25844504653 10.1084/jem.20050784 (Pubitemid 41396890)
11. Shevach E. M., Davidson T. S., Huter E. N., DiPaolo R. A., Andersson J., Role of TGF- β in the induction of Foxp3 expression and T regulatory cell function. Journal of Clinical Immunology 2008 28 6 640 646 2-s2.0-56649091213 10.1007/s10875-008-9240-1
12. Apostolou I., Sarukhan A., Klein L., von Boehmer H., Origin of regulatory T cells with known specificity for antigen. Nature Immunology 2002 3 8 756 763 2-s2.0-0036345337 10.1038/ni816
13. Jordan M. S., Boesteanu A., Reed A. J., Petrone A. L., Holenbeck A. E., Lerman M. A., Naji A., Caton A. J., Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nature Immunology 2001 2 4 301 306 2-s2.0-0035320679 10.1038/86302 (Pubitemid 33706340)
14. Lerman M. A., Larkin J. III, Cozzo C., Jordan M. S., Caton A. J., CD4+ CD25+ regulatory T cell repertoire formation in response to varying expression of a neo-self-antigen. Journal of Immunology 2004 173 1 236 244 2-s2.0-2942724435 (Pubitemid 38797347)
15. Cabarrocas J., Cassan C., Magnusson F., Piaggio E., Mars L., Derbinski J., Kyewski B., Gross D. A., Salomon B. L., Khazaie K., Saoudi A., Liblau R. S., Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage. Proceedings of the National Academy of Sciences of the United States of America 2006 103 22 8453 8458 2-s2.0-33744786828 10.1073/pnas.0603086103 (Pubitemid 43838476)
16. Lio C. W. J., Hsieh C. S., A two-step process for thymic regulatory T cell development. Immunity 2008 28 1 100 111 2-s2.0-37849009964 10.1016/j.immuni.2007.11.021
17. Lio C. W. J., Dodson L. F., Deppong C. M., Hsieh C. S., Green J. M., CD28 facilitates the generation of Foxp3-cytokine responsive regulatory T cell precursors. Journal of Immunology 2010 184 11 6007 6013 2-s2.0-77953415548 10.4049/jimmunol.1000019
18. Vang K. B., Yang J., Pagán A. J., Li L. X., Wang J., Green J. M., Beg A. A., Farrar M. A., Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoir. Journal of Immunology 2010 184 8 4074 4077 2-s2.0-77952767221 10.4049/jimmunol.0903933
19. Burchill M. A., Yang J., Vang K. B., Moon J. J., Chu H. H., Lio C. W. J., Vegoe A. L., Hsieh C. S., Jenkins M. K., Farrar M. A., Linked T Cell Receptor and Cytokine Signaling Govern the Development of the Regulatory T Cell Repertoire. Immunity 2008 28 1 112 121 2-s2.0-37849008688 10.1016/j.immuni.2007. 11.022
20. Gerondakis S., Banerjee A., Grigoriadis G., Vasanthakumar A., Gugasyan R., Sidwell T., Grumont R. J., NF- B subunit specificity in hemopoiesis. Immunological Reviews 2012 246 1 272 285 2-s2.0-84858716792 10.1111/j.1600-065X. 2011.01090.x
21. Macian F., NFAT proteins: key regulators of T-cell development and function. Nature Reviews Immunology 2005 5 6 472 484 2-s2.0-20644466433 10.1038/nri1632 (Pubitemid 40835035)
22. Hogan P. G., Chen L., Nardone J., Rao A., Transcriptional regulation by calcium, calcineurin, and NFAT. Genes and Development 2003 17 18 2205 2232 2-s2.0-0141483523 10.1101/gad.1102703 (Pubitemid 37128637)
23. Gupta S., Manicassamy S., Vasu C., Kumar A., Shang W., Sun Z., Differential requirement of PKC- θ in the development and function of natural regulatory T cells. Molecular Immunology 2008 46 2 213 224 2-s2.0-54349086262 10.1016/j.molimm.2008.08.275
24. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A. D., Stroud J. C., Bates D. L., Guo L., Han A., Ziegler S. F., Mathis D., Benoist C., Chen L., Rao A., FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006 126 2 375 387 2-s2.0-33746228122 10.1016/j.cell.2006.05.042 (Pubitemid 44092960)
25. Zeiser R., Nguyen V. H., Beilhack A., Buess M., Schulz S., Baker J., Contag C. H., Negrin R. S., Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 2006 108 1 390 399 2-s2.0-33745633856 10.1182/blood-2006-01-0329 (Pubitemid 43990654)
26. Tone Y., Furuuchi K., Kojima Y., Tykocinski M. L., Greene M. I., Tone M., Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nature Immunology 2008 9 2 194 202 2-s2.0-38349095578 10.1038/ni1549
27. Vaeth M., Schliesser U., Muller G., Reissig S., Satoh K., Tuettenberg A., Jonuleit H., Waisman A., Müller M. R., Serfling E., Sawitzki B. S., Berberich-Siebelt F., Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cells. Proceedings of the National Academy of Sciences of the United States of America 2012 109 40 16258 16263 10.1073/pnas.1203870109
28. Oh-hora M., rao A., The calcium/NFAT pathway: role in development and function of regulatory T cells. Microbes and Infection 2009 11 5 612 619 2-s2.0-67349260691 10.1016/j.micinf.2009.04.008
29. Bopp T., Palmetshofer A., Serfling E., Heib V., Schmitt S., Richter C., Klein M., Schild H., Schmitt E., Stassen M., NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells. Journal of Experimental Medicine 2005 201 2 181 187 2-s2.0-19944434216 10.1084/jem.20041538 (Pubitemid 40189426)
30. Bueno O. F., Brandt E. B., Rothenberg M. E., Molkentin J. D., Defective T cell development and function in calcineurin A β -deficient mice. Proceedings of the National Academy of Sciences of the United States of America 2002 99 14 9398 9403 2-s2.0-0037047152 10.1073/pnas.152665399 (Pubitemid 34764625)
31. Gallo E. M., Winslow M. M., Canté-Barrett K., Radermacher A. N., Ho L., McGinnis L., Iritani B., Neilson J. R., Crabtree G. R., Calcineurin sets the bandwidth for discrimination of signals during thymocyte development. Nature 2007 450 7170 731 735 2-s2.0-36749003787 10.1038/nature06305 (Pubitemid 350207686)
32. Neilson J. R., Winslow M. M., Hur E. M., Crabtree G. R., Calcineurin B1 is essential for positive but not negative selection during thymocyte development. Immunity 2004 20 3 255 266 2-s2.0-1642264751 10.1016/S1074-7613(04) 00052-4 (Pubitemid 38388228)
33. Li Q., Shakya A., Guo X., Zhang H., Tantin D., Jensen P. E., Chen X., Constitutive nuclear localization of NFAT in Foxp3+ regulatory T cells independent of calcineurin activity. Journal of Immunology 2012 188 9 4268 4277 2-s2.0-84860338668 10.4049/jimmunol.1102376
34. Medoff B. D., Sandall B. P., Landry A., Nagahama K., Mizoguchi A., Luster A. D., Xavier R. J., Differential requirement for CARMA1 in agonist-selected T-cell development. European Journal of Immunology 2009 39 1 78 84 2-s2.0-60549113390 10.1002/eji.200838734
35. Molinero L. L., Yang J., Gajewski T., Abraham C., Farrar M. A., Alegre M. L., CARMA1 controls an early checkpoint in the thymic development of foxP3 + regulatory T cells. Journal of Immunology 2009 182 11 6736 6743 2-s2.0-65549146581 10.4049/jimmunol.0900498
36. Schmidt-Supprian M., Courtois G., Tian J., Coyle A. J., Israël A., Rajewsky K., Pasparakis M., Mature T cells depend on signaling through the IKK complex. Immunity 2003 19 3 377 389 2-s2.0-0141678951 10.1016/S1074-7613(03) 00237-1 (Pubitemid 37153414)
37. Schmidt-Supprian M., Tian J., Grant E. P., Pasparakis M., Maehr R., Ovaa H., Ploegh H. L., Coyle A. J., Rajewsky K., Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF- B activation. Proceedings of the National Academy of Sciences of the United States of America 2004 101 13 4566 4571 2-s2.0-1842480966 10.1073/pnas.0400885101 (Pubitemid 38437451)
38. Gaide O., Favier B., Legler D. F., Bonnet D., Brissoni B., Valitutti S., Bron C., Tschopp J., Thome M., CARMAI is a critical lipid raft-associated regulator of TCR-induced NF- B activation. Nature Immunology 2002 3 9 836 843 2-s2.0-0036707522 10.1038/ni830
39. Jiang C., Lin X., Regulation of NF-kappaB by the CARD proteins. Immunological Reviews 2012 246 1 141 153 10.1111/j.1600-065X.2012.01110.x
40. Wang D., You Y., Case S. M., McAllister-Lucas L. M., Wang L., DiStefano P. S., Nuñez G., Bertin J., Lin X., A requirement for CARMAI in TCR-induced NF- B activation. Nature Immunology 2002 3 9 830 835 2-s2.0-0036707520 10.1038/ni824
41. Lin X., Wang D., The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling. Seminars in Immunology 2004 16 6 429 435 2-s2.0-8444225946 10.1016/j.smim.2004.08.022 (Pubitemid 39488023)
42. Sommer K., Guo B., Pomerantz J. L., Bandaranayake A. D., Moreno-García M. E., Ovechkina Y. L., Rawlings D. J., Phosphorylation of the CARMA1 linker controls NF- B activation. Immunity 2005 23 6 561 574 2-s2.0-28844500398 10.1016/j.immuni.2005.09.014 (Pubitemid 41779479)
43. Wang D., Matsumoto R., You Y., Che T., Lin X. Y., Gaffen S. L., Lin X., CD3/CD28 costimulation-induced NF- B activation is mediated by recruitment of protein kinase C- θ Bcl10, and I B kinase β to the immunological synapse through CARMA1. Molecular and Cellular Biology 2004 24 1 164 171 2-s2.0-0346993668 10.1128/MCB.24.1.164-171.2003 (Pubitemid 38010044)
44. Hoffmann A., Natoli G., Ghosh G., Transcriptional regulation via the NF- B signaling module. Oncogene 2006 25 51 6706 6716 2-s2.0-33750448661 10.1038/sj.onc.1209933 (Pubitemid 44657847)
45. Scheidereit C., I B kinase complexes: gateways to NF- B activation and transcription. Oncogene 2006 25 51 6685 6705 2-s2.0-33750443289 10.1038/sj.onc.1209934 (Pubitemid 44657846)
46. Oh H., Ghosh S., NF- B: roles and regulation in different CD4(+) T-cell subsets. Immunological Reviews 2013 252 1 41 51 10.1111/imr.12033
47. Isomura I., Palmer S., Grumont R. J., Bunting K., Hoyne G., Wilkinson N., Banerjee A., Proietto A., Gugasyan R., Li W., McNally A., Steptoe R. J., Thomas R., Shannon M. F., Gerondakis S., c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. Journal of Experimental Medicine 2009 206 13 3001 3014 2-s2.0-73949090725 10.1084/jem.20091411
48. Long M., Park S. G., Strickland I., Hayden M. S., Ghosh S., Nuclear factor- B modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. Immunity 2009 31 6 921 931 2-s2.0-71749088574 10.1016/j.immuni.2009.09.022
49. Ruan Q., Kameswaran V., Tone Y., Li L., Liou H. C., Greene M. I., Tone M., Chen Y. H., Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. Immunity 2009 31 6 932 940 2-s2.0-71749094333 10.1016/j.immuni.2009.10.006
50. Zheng Y., Josefowicz S., Chaudhry A., Peng X. P., Forbush K., Rudensky A. Y., Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010 463 7282 808 812 2-s2.0-76749133610 10.1038/nature08750
51. Deenick E. K., Elford A. R., Pellegrini M., Hall H., Mak T. W., Ohashi P. S., c-Rel but not NF- B1 is important for T regulatory cell development. European Journal of Immunology 2010 40 3 677 681 2-s2.0-77749245821 10.1002/eji.201040298
52. Grigoriadis G., Vasanthakumar A., Banerjee A., Grumont R., Overall S., Gleeson P., Shannon F., Gerondakis S., C-rel controls multiple discrete steps in the thymic development of Foxp3+ CD4 regulatory T cells. PLoS ONE 2011 6 10 2-s2.0-80055107550 10.1371/journal.pone.0026851 e26851
53. Lee A. J., Wu X., Cheng H., Zhou X., Cheng X., Sun S. C., CARMA1 regulation of regulatory T cell development involves modulation of interleukin-2 receptor signaling. Journal of Biological Chemistry 2010 285 21 15696 15703 2-s2.0-77952332355 10.1074/jbc.M109.095190
54. Rao S., Gerondakis S., Woltring D., Shannon M. F., c-Rel is required for chromatin remodeling across the IL-2 gene promoter. Journal of Immunology 2003 170 7 3724 3731 2-s2.0-0346195644 (Pubitemid 36359242)
55. Tai X., Cowan M., Feigenbaum L., Singer A., CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nature Immunology 2005 6 2 152 162 2-s2.0-13944260538 10.1038/ni1160 (Pubitemid 40268196)
56. Bour-Jordan H., Bluestone J. A., Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunological Reviews 2009 229 1 41 66 2-s2.0-65349151316 10.1111/j.1600-065X. 2009.00775.x
57. Salomon B., Lenschow D. J., Rhee L., Ashourian N., Singh B., Sharpe A., Bluestone J. A., B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000 12 4 431 440 2-s2.0-0033682056
58. Tang Q., Henriksen K. J., Boden E. K., Tooley A. J., Ye J., Subudhi S. K., Zheng X. X., Strom T. B., Bluestone J. A., Cutting edge: CD28 controls peripheral homeostasis of CD4 +CD25+ regulatory T cells. Journal of Immunology 2003 171 7 3348 3352 2-s2.0-0141920662 (Pubitemid 37254533)
59. Boise L. H., Minn A. J., Noel P. J., June C. H., Accavitti M. A., Lindsten T., Thompson C. B., CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-x(L). Immunity 1995 3 1 87 98 2-s2.0-0029163387
60. Burr J. S., Savage N. D. L., Messah G. E., Kimzey S. L., Shaw A. S., Arch R. H., Green J. M., Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL. Journal of Immunology 2001 166 9 5331 5335 2-s2.0-0035340150 (Pubitemid 32374151)
61. Thomas R. M., Gao L., Wells A. D., Signals from CD28 induce stable epigenetic modification of the IL-2 promoter. Journal of Immunology 2005 174 8 4639 4646 2-s2.0-17044410174
62. Nazarov-Stoica C., Surls J., Bona C., Casares S., Brumeanu T. D., CD28 signaling in T regulatory precursors requires p56lck and rafts integrity to stabilize the Foxp3 message. Journal of Immunology 2009 182 1 102 110 2-s2.0-59849109526
63. Fontenot J. D., Rasmussen J. P., Gavin M. A., Rudensky A. Y., A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nature Immunology 2005 6 11 1142 1151 2-s2.0-27544481941 10.1038/ni1263 (Pubitemid 41541792)
64. D'Cruz L. M., Klein L., Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nature Immunology 2005 6 11 1152 1159 2-s2.0-27544446622 10.1038/ni1264 (Pubitemid 41541793)
65. Bennett C. L., Christie J., Ramsdell F., Brunkow M. E., Ferguson P. J., Whitesell L., Kelly T. E., Saulsbury F. T., Chance P. F., Ochs H. D., The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genetics 2001 27 1 20 21 2-s2.0-0035167967 10.1038/83713 (Pubitemid 32044513)
66. Powell B. R., Buist N. R. M., Stenzel P., An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. Journal of Pediatrics 1982 100 5 731 737 2-s2.0-0020038580 (Pubitemid 12155977)
67. Wildin R. S., Ramsdell F., Peake J., Faravelli F., Casanova J. L., Buist N., Levy-Lahad E., Mazzella M., Goulet O., Perroni L., Dagna Bricarelli F., Byrne G., McEuen M., Proll S., Appleby M., Brunkow M. E., X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nature Genetics 2001 27 1 18 20 2-s2.0-0035163909 10.1038/83707 (Pubitemid 32044512)
68. Brunkow M. E., Jeffery E. W., Hjerrild K. A., Paeper B., Clark L. B., Yasayko S. A., Wilkinson J. E., Galas D., Ziegler S. F., Ramsdell F., Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature Genetics 2001 27 1 68 73 2-s2.0-0035162560 10.1038/83784 (Pubitemid 32044521)
69. Godfrey V. L., Wilkinson J. E., Russell L. B., X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. American Journal of Pathology 1991 138 6 1379 1387 2-s2.0-0026178213
70. Kim H. P., Leonard W. J., CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. Journal of Experimental Medicine 2007 204 7 1543 1551 2-s2.0-34447265236 10.1084/jem.20070109 (Pubitemid 47048022)
71. Yao Z., Kanno Y., Kerenyi M., Stephens G., Durant L., Watford W. T., Laurence A., Robinson G. W., Shevach E. M., Moriggl R., Hennighausen L., Wu C., O'Shea J. J., Nonredundant roles for Stat5a/b in directly regulating Foxp. Blood 2007 109 10 4368 4375 2-s2.0-34247564147 10.1182/blood-2006-11-055756 (Pubitemid 46743405)
72. Zorn E., Nelson E. A., Mohseni M., Porcheray F., Kim H., Litsa D., Bellucci R., Raderschall E., Canning C., Soiffer R. J., Frank D. A., Ritz J., IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 2006 108 5 1571 1579 2-s2.0-33747801470 10.1182/blood-2006-02-004747 (Pubitemid 44316124)
73. Burchill M. A., Yang J., Vogtenhuber C., Blazar B. R., Farrar M. A., IL-2 receptor β -dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. Journal of Immunology 2007 178 1 280 290 2-s2.0-33845935950 (Pubitemid 46033611)
74. Lal G., Zhang N., Van Der Touw W., Ding Y., Ju W., Bottinger E. P., Reid S. P., Levy D. E., Bromberg J. S., Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. Journal of Immunology 2009 182 1 259 273 2-s2.0-59849085588
75. Floess S., Freyer J., Siewert C., Baron U., Olek S., Polansky J., Schlawe K., Chang H. D., Bopp T., Schmitt E., Klein-Hessling S., Serfling E., Hamann A., Huehn J., Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biology 2007 5 2, article e38 2-s2.0-33847313682 10.1371/journal.pbio.0050038
76. Toker A., Huehn J., To be or not to be a Treg cell: lineage decisions controlled by epigenetic mechanisms. Science Signaling 2011 4 158, article pe4 2-s2.0-79551697900 10.1126/scisignal.2001783
77. Liu B., Tahk S., Yee K. M., Fan G., Shuai K., The ligase PIAS1 restricts natural regulatory T cell differentiation by epigenetic repression. Science 2010 330 6003 521 525 2-s2.0-77958173509 10.1126/science.1193787
78. Ouyang W., Beckett O., Ma Q., Paik J. H., Depinho R. A., Li M. O., Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nature Immunology 2010 11 7 618 627 2-s2.0-77953811224 10.1038/ni.1884
79. Lu L. F., Thai T. H., Calado D. P., Chaudhry A., Kubo M., Tanaka K., Loeb G. B., Lee H., Yoshimura A., Rajewsky K., Rudensky A. Y., Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 2009 30 1 80 91 2-s2.0-58149268107 10.1016/j.immuni.2008.11. 010
80. Kohlhaas S., Garden O. A., Scudamore C., Turner M., Okkenhaug K., Vigorito E., Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells1. Journal of Immunology 2009 182 5 2578 2582 2-s2.0-64849100152 10.4049/jimmunol.0803162